Senior Fellow, Protein Materials Engineering at University of Washington·2013 – 2020

Pitched protein materials to David Baker and got funded

My proposal to design conductive protein materials won Prof. David Baker's trust and an HFSP Cross-Disciplinary Fellowship.

Talk to me about
Co-Founder and CTO at ZipBio·2023 – 2025

Co-founded ZipBio to design drugs from scratch

As co-founder and CTO I built a de novo protein design-based drug discovery company, from 2023 to 2025.

Talk to me about
PhD, Organic Electronics at Technion - Israel Institute of Technology

Pioneered self-assembling vertical organic transistors

My PhD in organic electronics pioneered self-assembling vertical organic field-effect transistors (VOFETs).

Talk to me about
Scientific Advisor at Abiologics·2025 – now

Advise on mirror-image proteins at Abiologics

I help drive de novo protein engineering with Synteins, fully programmable mirrored-chirality proteins.

Talk to me about
Ariel Ben-Sasson

Ariel Ben-Sasson⁠

About

I'm Ariel, founder of molCore, a stealth biotech building next-generation programmable biologics. I designed the first two-component protein arrays published in Nature, trained as an HFSP Cross-Disciplinary Fellow in David Baker's lab at UW, and hold a PhD in organic electronics from Technion. I now advise Abiologics on their mirrored-chirality Syntein platform and Decycle Bio on design-build-test pipelines, while pushing de novo protein design and generative AI into drug discovery. Ask me about de novo protein design, generative AI for drug discovery, programmable biologics, and protein materials engineering.

Experiences

  1. Senior Fellow, Protein Materials Engineering at University of WashingtonPitched protein materials to David Baker and got funded

    My proposal to design conductive protein materials won Prof. David Baker's trust and an HFSP Cross-Disciplinary Fellowship.

  2. Co-Founder and CTO at ZipBioCo-founded ZipBio to design drugs from scratch

    As co-founder and CTO I built a de novo protein design-based drug discovery company, from 2023 to 2025.

  3. PhD, Organic Electronics at Technion - Israel Institute of TechnologyPioneered self-assembling vertical organic transistors

    My PhD in organic electronics pioneered self-assembling vertical organic field-effect transistors (VOFETs).

  4. Scientific Advisor at AbiologicsAdvise on mirror-image proteins at Abiologics

    I help drive de novo protein engineering with Synteins, fully programmable mirrored-chirality proteins.

Follow Ariel for more...

LinkedIn

© 2026 Delphi · Terms · Privacy

Ariel Ben-Sasson

Ariel Ben-Sasson⁠

About

I'm Ariel, founder of molCore, a stealth biotech building next-generation programmable biologics. I designed the first two-component protein arrays published in Nature, trained as an HFSP Cross-Disciplinary Fellow in David Baker's lab at UW, and hold a PhD in organic electronics from Technion. I now advise Abiologics on their mirrored-chirality Syntein platform and Decycle Bio on design-build-test pipelines, while pushing de novo protein design and generative AI into drug discovery. Ask me about de novo protein design, generative AI for drug discovery, programmable biologics, and protein materials engineering.

Experiences

  1. Senior Fellow, Protein Materials Engineering at University of WashingtonPitched protein materials to David Baker and got funded

    My proposal to design conductive protein materials won Prof. David Baker's trust and an HFSP Cross-Disciplinary Fellowship.

  2. Co-Founder and CTO at ZipBioCo-founded ZipBio to design drugs from scratch

    As co-founder and CTO I built a de novo protein design-based drug discovery company, from 2023 to 2025.

  3. PhD, Organic Electronics at Technion - Israel Institute of TechnologyPioneered self-assembling vertical organic transistors

    My PhD in organic electronics pioneered self-assembling vertical organic field-effect transistors (VOFETs).

  4. Scientific Advisor at AbiologicsAdvise on mirror-image proteins at Abiologics

    I help drive de novo protein engineering with Synteins, fully programmable mirrored-chirality proteins.

Follow Ariel for more...

LinkedIn

© 2026 Delphi · Terms · Privacy

By using this service, you agree to the Terms of Service and Privacy Policy.